Forbes May 13, 2023
By Joshua Cohen

This week, the Senate Health, Education, Labor and Pensions Committee advanced four new bills related to pharmacy benefit manager (PBM) and Food and Drug Administration reforms. This follows passage of five bipartisan bills out of the Senate Judiciary Committee in February.

The key piece of legislation, known as the Pharmacy Benefit Manager Reform Act, was ultimately agreed to by a vote of 18-3. This implies that the legislation will go to the floor of the Senate to be debated and eventually voted on.

The Pharmacy Benefit Manager Reform Act (S. 1339), led by Chairman Sanders (I-VT) and Ranking Member Cassidy (R-LA), bans spread pricing and certain claw backs by PBMs, and requires that rebates be passed through to plan sponsors.

...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
FTC pauses PBM litigation in win for Caremark, Express Scripts, Optum Rx
Pharma Dodges The Tariff Bullet — But For How Long?
Robots can aid hospital pharmacies in safer and more sustainable cancer drug preparation
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Q&A: How can drug repurposing lower drug costs and improve care?

Share This Article